• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

FDA Webinar on "Bad Ads" Program

DATE:  April 28, 2011
TIME:  12:00 p.m.

To join the meeting:
https://collaboration.fda.gov/badad/

The FDA’s BadAd Project helps the Agency’s Division of Drug Marketing, Advertising, and Communications (DDMAC) monitor drug companies’ promotional messages for fair balance and truthfulness. Learn how FDA is recruiting the assistance of healthcare professionals to help end misleading drug promotions. Examples include:

  • A presentation about a prescription drug that tells the drug’s benefits but not its risks;
  • A sales representative tells a doctor a prescription drug is effective for a use not in the FDA-approved product labeling;
  • A sales representative says, “Drug X delivers results in as little as 3 days,” but does not mention that clinical trials showed most results took 12 weeks, with only few in 3 days.

FDA’s BadAd program helps protect the public. This presentation explains how.

Basics Question toggle Show all related FDA Basics Questions

-

How helpful was this information?

                               

Not HelpfulArrow pointing to the rightVery Helpful


Please limit your feedback to 1000 characters.

Please limit your feedback to 1000 characters.

If you would like to ask a specific question, please visit our "Contact Us" page for more information about how to contact FDA.

Please note that any information you submit may become public or subject to release under the Freedom of Information Act (FOIA). For more information, read about our privacy policies and the FOIA.

-